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Abstract
Aim of the work. Analysis of the possibilities of the different methods of RFA of lung and pleura tumors. 
Material and methods. There were considered the different methods of radio-frequency ablations using FOTEK-150 appara-
tus in 186 patients with the malignant tumors of lungs and pleura. 
Results. In the result of use of the different methods of radio-frequency ablation the direct positive effect was attained in 
91 % of observations. The complications were observed in 9 % of patients. This method must be used for patients with the malignant 
tumors of lungs and pleura when the radical surgical treatment is impossible. 
Conclusions. The radio-frequency ablation can be used as a palliative method of treatment of the malignant tumors of 
lungs and pleura. 
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1. Introduction
The method of radio-frequency ablation (RFA) is based on the effect of effervescence of 
intracellular liquid with destruction of the tumor cells using the radio-frequency airwaves delivered 
to the tumor with the help of special electrode [1–2, 5–6, 10]. Radio-frequency ablation is widely 
used in the treatment of malignant tumors of liver. The publications about the use of this method 
at the primary and metastatic lung cancer appeared last years. Theoretically it can be effectively 
used for RFA because the ambient air allows concentrate the energy of RF-eradiation directly in 
the node preventing the lesion of the large volume of lung parenchyma. 
It is much less spread in endobronchial surgery [7, 9] and practically not used in the treat-
ment of metastatic lesion of pleura. 
The use of the method of radio-frequency ablation in the treatment of the central lung cancer 
as well as at the secondary pleurisy is a new direction in the palliative treatment of lung cancer 
and its complications. Among these complications must be named the tumor stenosis of trachea 
and bronchi, metastatic pleurisy. The use of RFA at these complications improves the patients’ life 
quality and prolongs their life. 
Methods of VATS RFA of lung tumors at the open operations are the author’s elaborations 
that are in the process of research. In the further after collecting the sufficient number of patients 
we plan to devote the separate article to these types of interventions. 
Authors who used this method in the treatment of the primary and metastatic lung cancer 
noted the positive palliative effect [1–6]. The sphere of the use of this method is usually used by the 
peripheral lung tumors when the surgical intervention was impossible [2–6, 8, 10]. All aforesaid allowed 
share the primary experience of RFA use in the treatment of malignant tumors of lungs and pleura. 
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2. Aim of the work
Analysis of the possibilities of the different methods of RFA of the lung and pleura tumors. 
3. Material and methods
In hospital the different RFA methods were carried out in 186 patients: 75 men and 33 wom-
en 48–79 years old. Among the studied group of patients the primary lung cancer was in 145 cases. 
By the morphological tumor structure 71 had the squamous cell cancer, 25 – small cell, 49 – 
glandular one. Metastatic lung cancer was observed in 41 patients. Most patients were refused in 
the surgical treatment because of tumor spread 0 54, because of the heavy concomitant pathology 
and age – 25. 32 ones were refused in chemoradiotherapy. 
The high-frequency electrosurgical device for the volume coagulation of biological tissues 
ESHF-150 “FOTEK” with output power up to 80 W was used as an apparatus for RFA. Electrode 
EM-218 was used directly for the volume coagulation. 
For endobronchial RFA was used endocardial electrode for cardioablation. 
The types and used methods of RFA are presented in the Table 1. 
Table 1
Types of RFA methods in the treatment of lung and pleura tumors 
RFA method Number of observation 
1. Puncture transtoracic RFA 61
2. VATS RFA of tumor 15
3. RFA at transtoracic open interventions 10
4. Endobronchial RFA with recanalization of the tumor stenosis 75
5. RFA pleurodesis at metastatic pleurisy 25
The method of transtoracic RFA is a transdermal insertion in the tumor of the aforesaid 
electrode using angiographic complex Allara Xper FD – 20 «Phillips». Operation was carried out 
from the side access under intravenous anesthesia without intubation of trachea. The X-ray control 
demonstrated the position of electrode in the tumor. In several cases electrode was put in the differ-
ent parts of tumor. The parameters of the momentary RFA were: the output power of impact 60 W, 
the time of exposition 40–60 seconds, and in several cases the thermal impact of air waves was 
repeated. After the end of RFA the X-ray control was carried out to excluding pneumothorax. 
At RFA under VATS control was used the general anesthesia with exclusion of the operated 
lung from respiration. Operation was carried out from the side access with insertion of video-cam-
era through the 10 mm thoracoport in V–VI intercostals spaces on the middle-back axillary lines. 
After visual assessment of lesion depending on localization of the peripheral tumor the electrode 
was transtoracically put in it. RFA was carried out under the visual control using the puncture of 
tumor from the different points. The parameters of impact did not differ from the aforesaid ones. 
Operation was finished by insertion of drainage and smoothing of the lung. 
At the open method of RFA was used the standard side thoracotomy in V intercostals space. 
After the revision and assessment of the lesion volume the radio-frequency electrode was put in the 
tumor tissue from the different points. The RFA parameters corresponded to the aforesaid ones. 
The method of RFA and pleurodesis at metastatic pleurisy corresponded to the VATS one. But RFA 
was carried out on the parts of parietal pleura by the subpleural insertion of electrode. For these 
aims was used the elongate electrode that allows manipulate in the different parts of hemithorax. At 
presence of metastatic nodes on pleura RFA was carried out by putting electrode under their base, 
their diameter was 0,5–3,0 cm.
Endobronchial RFA was carried out under the local anesthesia using fibrobronchoscopes 
«Olympys, Pentax». RFA was carried out by the contact between electrode and tumor. At the 
beginning was realized the destruction of the surface tumor layers then of its deeper parts, at this 
process was used the output power 30 W with the time of impact 20–40 seconds. 3 operations were 
usually needed for the full RFA and renewal of patency. 
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4. Results of research
RFA of the primary and metastatic tumors of lungs and pleura was realized when the rad-
ical surgical treatment was considered as impossible that is proved by the data of other authors 
[2–6, 8, 10]. In our series of observations the direct positive effect of RFA such as destruction 
of tumor at the use of puncture method was noticed in 87 % of patients. Among 61 analyzed pa-
tients the survivability in terms up to 1 year – 84 % of patients, to 2 years – 63 % of patients, 
to 3 years – 49 % of patients.
The most spread complication of this method is pneumothorax that is observed in 20 % 
of patients [4, 8]. The other complications of RFA are seldom and do not exceed 0,6 % [4]. In our 
series of observations pneumothorax was observed in 13 % of patients and easily eliminated by the 
drainage of pleural cavity during 1–2 days. The complications such as hemoptysis are very seldom. 
In our observation it was observed in 0,3 % of patients.
RFA at the open operative interventions was used in 10 patients. This method was real-
ized when at the operative intervention was revealed that elimination of tumor is impossible. For 
decrease of the tumor sizes it was ablated with the further chemotherapy of radiotherapy. On the 
control CT of the chest organs in 1 month after RFA the tumor sizes decreased in 2–3 times. Then 
the special treatment was realized. 
We carried out RFA of trachea and bronchi in 75 patients with the tumor stenosis of respi-
ratory tract as a palliative measure. The local anesthesia allows use it even in patients with severe 
respiratory insufficiency. The use of RFA and recanalization is considered as possible at exophytic 
form of endobronchial tumor with preservation of the anatomic reference points as the bronchi-
al wall and partially preserved bronchi clearance. Peribronchial bronchi compression makes this 
method useless and even dangerous. 
The existing numerous methods of pleurodesis at metastatic exudative pleurisy indicate the 
absence of the unified effective methodology of treatment. The elaborated method of VATS RFA 
of parietal pleura for creation of pleurodesis was used in 25 patients with metastatic exudative 
pleurisy. At the same time exists the possibility of elimination of the large metastases on parietal 
pleura 0,5–3 cm. 
In the result the direct positive effect, the stop of exudation, was attained in 91 % of pa-
tients. In terms of observation up to 1 year the relapse of pleurisy was observed in 2 patients. It 
is worth noting, that realization of this method of pleurodesis was successfully underwent by this 
heavy category of patients. Any complications in the early postoperative period were not observed. 
The mean terms f drainage of the pleural cavity were 2–3 days and the patient’s stay in hospital – 
4–5 days. The elaborated method of pleurodesis is rather simple but assessment of its effectiveness 
needs further collection of the clinic material. 
Radio-frequency ablation in combination with VATS was carried out in 15 patients. The 
positive result as a destruction of tumor was attained in у 100 % of patients, the complication as 
hemoptysis was observed in 1 patient. On the control CT in 5 month after RFA the relapse of tumor 
was not observed. 
5. Discussion of the results of research
According to S. Jain and co-authors (5) RFA allows essentially add the other methods of 
conservative treatment of tumors despite its palliative character. Although, according to Т. Scheider 
and co-authors [8] the full necrosis of tumor after RFA is observed in 37,5 % of cases, this method 
must not replace the radical operations if possible. The main method of RFA of lung tumors is 
puncture transtoracic way carried out under the control of computed tomography [2–6, 10]. The 
own experience demonstrated the possibility to use x-ray angiographic set for such purposes. At 
the same time the permanent x-ray control on the position of electrode in tumor allows carry out 
RFA from the different points. In addition after the end of RFA appears a possibility to detect the 
probable pneumothorax and make the timely drainage of pleural cavity. 
Like other authors [5–6, 8] we observed the primary appearance of edema and infiltration in 
the RFA zone with the further decrease of lesion zone, corrugation and scarring of the wound tu-
mor. In several cases can take place the transformation of the tumor tissue into pseudocyst [9]. The 
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direct effectiveness of RFA of the lung tumors is rather high, thus, A. Baisi and co-authors [2] noted 
the positive effect of RFA in 95 % of patients with the peripheral tumor less than 5 cm and at 3 cm 
tumor the 5-years survivability reached 50% that is proved by the other authors [4]. O. N. Kacha-
nov and S. V. Kozlov [1] did not reveal any difference in treatment after the comparative analysis 
of survivability after RFA and atypical resection of metastases of squamous cell cancer. But the 
progressing of the tumor process after RFA was noticed in 23 % of patients [4]. The significant 
advantages of puncture RFA is an objective control on the tumor destruction, low cost price with 
satisfactory frequency of complication and lethality [5, 18–20].
RFA under the VATS control has some advantages; visual control on RFA makes an inter-
vention significantly different and allows the maximal impact of high-frequency waves on tumor. 
Unfortunately the realization of these methods needs endotracheal and one-lung anesthesia that is 
not always possible in elderly patients with expressed concomitant pathology. The direct positive 
effect of RFA was attained in all patients. Such complication as hemoptysis was observed in 1 pa-
tients and was treated conservatively. Combination of two methods allowed carry out RFA pleurod-
esis on parietal pleura in patients with small metastases (1–2 mm. This type of pleurodesis is more 
effective than the earlier known [12–17] because it allows carry out metastasectomy. 
The method of RFA at open operative interventions is also the author’s one. The positive 
effect as the decrease of tumor was attained in 100 % of cases. The defect of this method is an 
impossibility to control the process of ablation and assess the results of RFA during the operation. 
At the same time with an impact on the tumor can be carried out RFA of the lymph nodes 
of mediastinum. 
There are no contradictions to this operative intervention. Any complications were not ob-
served during the operation and postoperative period. 
The experience of use of endobronchial RFA of tumor is essentially limited [7, 9]. Thus, 
T. Tanabe and co-authors [9] used this method at treatment of the central forms of lung cancer of 
I stage. The impact was realized using the special electrode with its internal cooling with liquid 
under the control of computed tomography. The further surgical treatment with morphological 
examination demonstrated that this method can be used as an independent one when the operative 
treatment is impossible. Taking into account that we mainly used this method in patients with 
I–IV stages of lung cancer, it is difficult to compare our results because it is not described for 
this category of patients by any author. After RFA the patients’ life quality and the parameter of 
external respiratory function improved. The single complication was hemoptysis that appeared in 
2 patients in our research and was eliminated by medicaments. 
6. Conclusions
So, the collected primary experience of RFA of pleura and lung tumors allows make the 
following conclusions:
1. RFA can be the method of choice in treatment of the peripheral cancerous tumors and 
lung metastases in cases when surgical treatment is considered as impossible. 
2. The main method of RFA of such tumors can be the transtoracic puncture under x-ray control. 
3. The use of RFA of tumors at open and VATS operations needs the further study. 
4. The methods of endobronchial RFA and creation of pleurodesis need the further collec-
tion of clinical experience and objective assessment. 
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